Renfu Pharmaceutical announced that the holding subsidiary Yichang Renfu Pharmaceutical Co., Ltd. recently received the HW231019 “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration.

Zhitongcaijing · 03/11 08:41
Renfu Pharmaceutical announced that the holding subsidiary Yichang Renfu Pharmaceutical Co., Ltd. recently received the HW231019 “Drug Clinical Trial Approval Notice” approved and issued by the State Drug Administration.